BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3902087)

  • 1. The p53 cellular tumor antigen: gene structure, expression and protein properties.
    Oren M
    Biochim Biophys Acta; 1985 Nov; 823(1):67-78. PubMed ID: 3902087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary structure of DNA complementary to mRNA of murine oncoprotein p53].
    Chumakov PM
    Bioorg Khim; 1987 Dec; 13(12):1691-4. PubMed ID: 3329909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular oncogene p53 can be activated by mutagenesis.
    Jenkins JR; Rudge K; Chumakov P; Currie GA
    Nature; 1985 Oct 31-Nov 6; 317(6040):816-8. PubMed ID: 3903515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transformation-related p53 protein: a potential regulator of cell proliferation.
    Mercer WE; Baserga R
    Prog Clin Biol Res; 1985; 177():171-91. PubMed ID: 2409558
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.
    Jenkins JR; Rudge K; Redmond S; Wade-Evans A
    Nucleic Acids Res; 1984 Jul; 12(14):5609-26. PubMed ID: 6379601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Mr 53,000 protein with induction of differentiation of human neuroblastoma cells.
    Sidell N; Koeffler HP
    Cancer Res; 1988 Apr; 48(8):2226-30. PubMed ID: 3280124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of p53 antigen makes established cells highly tumorigenic.
    Eliyahu D; Michalovitz D; Oren M
    Nature; 1985 Jul 11-17; 316(6024):158-60. PubMed ID: 3892307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure polymorphism at amino acid residue 72 of human p53.
    Matlashewski GJ; Tuck S; Pim D; Lamb P; Schneider J; Crawford LV
    Mol Cell Biol; 1987 Feb; 7(2):961-3. PubMed ID: 3547088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meth A fibrosarcoma cells express two transforming mutant p53 species.
    Eliyahu D; Goldfinger N; Pinhasi-Kimhi O; Shaulsky G; Skurnik Y; Arai N; Rotter V; Oren M
    Oncogene; 1988 Sep; 3(3):313-21. PubMed ID: 3060794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell immortalization and transformation by the p53 gene.
    Lane DP
    Nature; 1984 Dec 13-19; 312(5995):596-7. PubMed ID: 6095111
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of rearrangements of p53 tumor antigen gene locus in human hematological malignancies.
    Venturelli D; Ku DH; Narni F; Gatti C; Calabretta B
    Haematologica; 1988; 73(4):259-64. PubMed ID: 3139527
    [No Abstract]   [Full Text] [Related]  

  • 12. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.
    Shih JY; Yang SC; Hong TM; Yuan A; Chen JJ; Yu CJ; Chang YL; Lee YC; Peck K; Wu CW; Yang PC
    J Natl Cancer Inst; 2001 Sep; 93(18):1392-400. PubMed ID: 11562390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
    Matlashewski G; Lamb P; Pim D; Peacock J; Crawford L; Benchimol S
    EMBO J; 1984 Dec; 3(13):3257-62. PubMed ID: 6396087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the p53 oncogene in acute myeloblastic leukemia.
    Smith LJ; McCulloch EA; Benchimol S
    J Exp Med; 1986 Sep; 164(3):751-61. PubMed ID: 2427633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Michalovitz D; Halevy O; Oren M
    Cell; 1990 Aug; 62(4):671-80. PubMed ID: 2143698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells.
    Reich NC; Levine AJ
    Nature; 1984 Mar 8-14; 308(5955):199-201. PubMed ID: 6366574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-operation between the p53 protein tumor antigen and platelet-poor plasma in the induction of cellular DNA synthesis.
    Kaczmarek L; Oren M; Baserga R
    Exp Cell Res; 1986 Jan; 162(1):268-72. PubMed ID: 3509995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia.
    Munroe DG; Rovinski B; Bernstein A; Benchimol S
    Oncogene; 1988 Jun; 2(6):621-4. PubMed ID: 3290808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of human p53 transcripts.
    Matlashewski G; Pim D; Banks L; Crawford L
    Oncogene Res; 1987 Jun; 1(1):77-85. PubMed ID: 2453013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic p53 gene immortalises.
    Oncogene; 1988 May; 2(5):419-20. PubMed ID: 3287277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.